GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Debt-to-Asset

Implantica AG (OSTO:IMP A SDB) Debt-to-Asset : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Debt-to-Asset?

Implantica AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was kr0.00 Mil. Implantica AG's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in . 20 was kr0.00 Mil.

Implantica AG Debt-to-Asset Historical Data

The historical data trend for Implantica AG's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Debt-to-Asset Chart

Implantica AG Annual Data
Trend
Debt-to-Asset

Implantica AG Semi-Annual Data
Debt-to-Asset

Competitive Comparison of Implantica AG's Debt-to-Asset

For the Medical Devices subindustry, Implantica AG's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Implantica AG's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Implantica AG's Debt-to-Asset falls into.


;
;

Implantica AG Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Implantica AG's Debt-to-Asset for the fiscal year that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

Implantica AG's Debt-to-Asset for the quarter that ended in . 20 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implantica AG  (OSTO:IMP A SDB) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Implantica AG Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Implantica AG's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Debt-to-Asset
Comparable Companies
Traded in Other Exchanges
8IM1:Germany
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Website
https://www.implantica.com
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. To bring advanced technology into the body, and adequate energy supply is required which would require very large batteries, so, Implantica has developed a wireless energising platform to supply energy to the body through intact skin.

Implantica AG Headlines

No Headlines